Washington, United States | AFP | The United States on Monday withdrew emergency use authorizations for two antimalarial drugs favored by President Donald Trump to treat the new coronavirus, effectively shutting the door on the politically charged treatments. Hydroxychloroquine (HCQ) and chloroquine (CQ) were authorized in March after they were found …
Read More »Hydroxychloroquine: a drug dividing the world
Paris, France | AFP | Banned in some countries, promoted in others — the drug hydroxychloroquine as a potential treatment for the new coronavirus is dividing opinion worldwide. Scientists looking to find licenced medicines that could be repurposed as a treatment for COVID-19 had started tests of hydroxychloroquine, normally used to …
Read More »Scientists raise concern over hydroxychloroquine study
Paris, France | AFP | Dozens of scientists have raised concerns over a large-scale study of hydroxychloroquine and chloroquine published in the Lancet that led to the World Health Organization suspending clinical trials of the anti-viral drugs as a potential treatment for COVID-19. Hydroxychloroquine, normally used to treat arthritis, has become …
Read More »Uganda records good results treating COVID with hydroxychloroquine, chloroquine
Kampala, Uganda | THE INDEPENDENT | The Ministry of Health says it has had good results using hydroxychloroquine and chloroquine in managing COVID-19 patients despite findings that the drugs have no effect on treating the disease. Uganda has used the two drugs in combination with azithromycin to manage its COVID-19 patients …
Read More »Study finds hydroxychloroquine and chloroquine ineffective for COVID treatment
Kampala, Uganda | THE INDEPENDENT | A new study has found that the two drug regimens; Hydroxychloroquine and chloroquine, that have been widely used in the treatment of COVID-19 are ineffective. The drugs instead lowered the chances of survival for those who used them, according to a reported published in the …
Read More »Hydroxychloroquine shows no virus benefit, raises death risk: study
Paris, France | AFP | A study of nearly 100,000 coronavirus patients has shown no benefit in treating them with anti-viral drugs hydroxychloroquine and chloroquine and even increased the likelihood of them dying in hospital. Hydroxychloroquine is normally used to treat arthritis but pronouncement from public figures including US President Donald …
Read More »‘Serious side effects’ from Trump-backed virus drugs: EU agency
The Hague, Netherlands | AFP | The European Medicines Agency on Thursday added its voice to growing concern about an anti-malarial drug widely touted as a potential cure for the COVID-19 disease, warning about fatal side effects. Beneficial effects of chloroquine and hydroxychloroquine, which count US President Donald Trump as a major backer, have “not …
Read More »COVID-19 treatment-: Hydroxychloroquine to be more frequently used than chloroquine
Kampala, Uganda | THE INDEPENDENT | Patients being treated for coronavirus –COVID-19 in Uganda are set to be shifted from having common anti-malarial drug chloroquine among their treatment plan to hydroxychloroquine. This decision according to Prof. Pauline Byakika, a member of the COVID-19 National Case Management Committee is being reached …
Read More »No benefit, higher death rate for malaria drug in coronavirus study
Washington, United States | AFP | A malaria drug widely touted as a potential cure for COVID-19 showed no benefit against the disease over standard care — and was in fact associated with more deaths, the biggest study of its kind showed Tuesday. The US government funded analysis of how American …
Read More »Health facilities fail to restock chloroquine over high prices
Kampala, Uganda | THE INDEPENDENT | Most private health facilities in Kitgum Municipality have failed to increase on their stock of chloroquine because of exorbitant prices in pharmacies across the region. Until recently, chloroquine has been widely available and would cost Shillings 200 and Shillings 300 in health facilities in …
Read More »